Company Limited (“the Company”) No. 5/2020, held on June 16, 2020, has unanimously resolved approve as followings. 1. Approve for the Company to participate the vote of approval in the Extraordinary General
dispute between a provident fund member and the respondent, provided that the claimant shall demonstrate a written evidence or agreement that the respondent gives consent to resolve the dispute by the
securities business, or the dispute between a provident fund member and the respondent, provided that the claimant shall demonstrate a written evidence or agreement that the respondent gives consent to resolve
securities business, or the dispute between a provident fund member and the respondent, provided that the claimant shall demonstrate a written evidence or agreement that the respondent gives consent to resolve
The Company had recorded net gain from write-off expired legal prescription of debts for year 2018 amounted to THB 119 million according to the resolve approval from the Company’s Board of Directors on
expired legal prescription of debts for year 2018 amounted to THB 119 million according to the resolve approval from the Company’s Board of Directors on 9th and 19th November 2018. 5. Performance of the
________________________ By virtue of Paragraph 1 of Section 109 and Paragraph 1(2) of Section 141 of the Securities and Exchange Act B.E. 2535 (1992) , with the approval of the Capital Market Supservisory Board, Section19
________________________ By virtue of Paragraph 1 of Section 109 and Paragraph 1(2) of Section 141 of the Securities and Exchange Act B.E. 2535 (1992), with the approval of the Capital Market Supservisory Board, Section19
Province 73210, has considered and resolved to approve the Company’s execution of transactions with the connected persons as per the following details: The Board of Directors has resolved to grant approval
authorization of Mr. Vorasit Pokachaiyapat or person(s) authorized by Mr. Vorasit Pokachaiyapat, to have the authorizations to consider and decide on conditions and details related to the acquisition of shares of